Endothelial mechanotransduction proteins and vascular function are altered by dietary sucrose supplementation in healthy young male subjects

J Physiol. 2017 Aug 15;595(16):5557-5571. doi: 10.1113/JP274623.

Abstract

Key points: Mechanotransduction in endothelial cells is a central mechanism in the regulation of vascular tone and vascular remodelling Mechanotransduction and vascular function may be affected by high sugar levels in plasma because of a resulting increase in oxidative stress and increased levels of advanced glycation end-products (AGE). In healthy young subjects, 2 weeks of daily supplementation with 3 × 75 g of sucrose was found to reduce blood flow in response to passive lower leg movement and in response to 12 W of knee extensor exercise. This vascular impairment was paralleled by up-regulation of platelet endothelial cell adhesion molecule (PECAM)-1, endothelial nitric oxide synthase, NADPH oxidase and Rho family GTPase Rac1 protein expression, an increased basal phosphorylation status of vascular endothelial growth factor receptor 2 and a reduced phosphorylation status of PECAM-1. There were no measurable changes in AGE levels. The findings of the present study demonstrate that daily high sucrose intake markedly affects mechanotransduction proteins and has a detrimental effect on vascular function.

Abstract: Endothelial mechanotransduction is important for vascular function but alterations and activation of vascular mechanosensory proteins have not been investigated in humans. In endothelial cell culture, simple sugars effectively impair mechanosensor proteins. To study mechanosensor- and vascular function in humans, 12 young healthy male subjects supplemented their diet with 3 × 75 g sucrose day-1 for 14 days in a randomized cross-over design. Before and after the intervention period, the hyperaemic response to passive lower leg movement and active knee extensor exercise was determined by ultrasound doppler. A muscle biopsy was obtained from the thigh muscle before and after acute passive leg movement to allow assessment of protein amounts and the phosphorylation status of mechanosensory proteins and NADPH oxidase. The sucrose intervention led to a reduced flow response to passive movement (by 17 ± 2%) and to 12 W of active exercise (by 9 ± 1%), indicating impaired vascular function. A reduced flow response to passive and active exercise was paralleled by a significant up-regulation of platelet endothelial cell adhesion molecule (PECAM-1), endothelial nitric oxide synthase, NADPH oxidase and the Rho family GTPase Rac1 protein expression in the muscle tissue, as well as an increased basal phosphorylation status of vascular endothelial growth factor receptor 2 and a reduced phosphorylation status of PECAM-1. The phosphorylation status was not acutely altered with passive leg movement. These findings indicate that a regular intake of high levels of sucrose can impair vascular mechanotransduction and increase the oxidative stress potential, and suggest that dietary excessive sugar intake may contribute to the development of vascular disease.

Keywords: mechanosensor; passive leg movement; vascular function.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD / physiology
  • Cadherins / physiology
  • Cross-Over Studies
  • Dietary Sucrose / pharmacology*
  • Epoprostenol / physiology
  • Exercise / physiology
  • Femoral Artery / physiology
  • Glycation End Products, Advanced / blood
  • Humans
  • Leg / physiology
  • Male
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / physiology
  • Nitric Oxide Synthase Type III / physiology
  • Nitrogen Oxides / blood
  • Phosphorylation
  • RNA, Messenger / metabolism
  • Receptor for Advanced Glycation End Products / blood
  • Regional Blood Flow
  • Signal Transduction
  • Vascular Endothelial Growth Factor Receptor-2 / physiology
  • Young Adult

Substances

  • Antigens, CD
  • Cadherins
  • Dietary Sucrose
  • Glycation End Products, Advanced
  • Nitrogen Oxides
  • RNA, Messenger
  • Receptor for Advanced Glycation End Products
  • cadherin 5
  • Epoprostenol
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2